Literature DB >> 19760485

The effect of electroaucpuncture for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced proteomic changes in the mouse striatum.

Seung-Tae Kim1, Woongjoon Moon, Younbyoung Chae, Youn Jung Kim, Hyejung Lee, Hi-Joon Park.   

Abstract

Using a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Parkinson's disease mouse model, we investigated protein expression changes associated with the action of electroacupuncture (EA) in the mouse striatum. Twelve-week-old male C57BL/6 mice were injected intraperitoneally with 30 mg/kg of MPTP at 24-h intervals for 5 days, and the 100-Hz EA stimulation was performed at GB34 and GB39 once a day for 12 days consecutively from the first injection. With the EA, the MPTP-induced dopaminergic neuronal destruction was reduced. Of the 13 proteins that were differentially expressed between control and MPTP treated mice, cytosolic malate dehydrogenase, munc18-1, and hydroxyacylglutathione hydrolase, which were increased by MPTP, and cytochrome c oxidase subunit Vb, which was decreased by MPTP, were restored to the level of the saline group after EA treatment. These proteins are likely related to cellular metabolism. Altogether, we propose that the EA may exert neuroprotective effects in mice striatum through reducing MPTP-induced toxicity such as oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19760485     DOI: 10.1007/s12576-009-0061-7

Source DB:  PubMed          Journal:  J Physiol Sci        ISSN: 1880-6546            Impact factor:   2.781


  35 in total

Review 1.  Parkinson's disease: a major hypokinetic basal ganglia disorder.

Authors:  J Sian; M Gerlach; M B Youdim; P Riederer
Journal:  J Neural Transm (Vienna)       Date:  1999       Impact factor: 3.575

2.  Acupuncture treatment of Parkinson's disease--a report of 29 cases.

Authors:  X Zhuang; L Wang
Journal:  J Tradit Chin Med       Date:  2000-12       Impact factor: 0.848

3.  Long-term high-frequency electro-acupuncture stimulation prevents neuronal degeneration and up-regulates BDNF mRNA in the substantia nigra and ventral tegmental area following medial forebrain bundle axotomy.

Authors:  Xi-Bin Liang; Xian-Yu Liu; Feng-Qiao Li; Yong Luo; Jun Lu; Wang-Ming Zhang; Xiao-Min Wang; Ji-Sheng Han
Journal:  Brain Res Mol Brain Res       Date:  2002-12

4.  VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity.

Authors:  N Takahashi; L L Miner; I Sora; H Ujike; R S Revay; V Kostic; V Jackson-Lewis; S Przedborski; G R Uhl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-02       Impact factor: 11.205

5.  Cytosolic malate dehydrogenase confers selectivity of the nucleic acid-conducting channel.

Authors:  Basil Hanss; Edgar Leal-Pinto; Avelino Teixeira; Robert E Christian; Jeffery Shabanowitz; Donald F Hunt; Paul E Klotman
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

Review 6.  Iron metabolism and Parkinson's disease.

Authors:  E C Hirsch; B A Faucheux
Journal:  Mov Disord       Date:  1998       Impact factor: 10.338

7.  wasted away, a Drosophila mutation in triosephosphate isomerase, causes paralysis, neurodegeneration, and early death.

Authors:  Joshua P Gnerer; Robert A Kreber; Barry Ganetzky
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-28       Impact factor: 11.205

Review 8.  Glyoxalase II: molecular characteristics, kinetics and mechanism.

Authors:  D L Vander Jagt
Journal:  Biochem Soc Trans       Date:  1993-05       Impact factor: 5.407

Review 9.  Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors.

Authors:  P J Thornalley
Journal:  Chem Biol Interact       Date:  1998-04-24       Impact factor: 5.192

10.  Regulation of dopaminergic loss by Fas in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.

Authors:  Shawn Hayley; Stephen J Crocker; Patrice D Smith; Tanaya Shree; Vernice Jackson-Lewis; Serge Przedborski; Matthew Mount; Ruth Slack; Hymie Anisman; David S Park
Journal:  J Neurosci       Date:  2004-02-25       Impact factor: 6.167

View more
  22 in total

Review 1.  Traditional Chinese medicine for modern treatment of Parkinson's disease.

Authors:  Lu Han; Yuan-Hong Xie; Rong Wu; Chen Chen; Yan Zhang; Xiao-Ping Wang
Journal:  Chin J Integr Med       Date:  2017-01-20       Impact factor: 1.978

2.  Acupuncture stimulation at GB34 suppresses 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced oxidative stress in the striatum of mice.

Authors:  Yukyung Lee; Gaeun Choi; Hyongjun Jeon; Dongsoo Kim; Sun Ryu; Sungtae Koo; Ki-Tae Ha; Seungtae Kim
Journal:  J Physiol Sci       Date:  2017-06-10       Impact factor: 2.781

3.  Bee Venom Acupuncture Alleviates Experimental Autoimmune Encephalomyelitis by Upregulating Regulatory T Cells and Suppressing Th1 and Th17 Responses.

Authors:  Min Jung Lee; Minhee Jang; Jonghee Choi; Gihyun Lee; Hyun Jung Min; Won-Seok Chung; Jong-In Kim; Youngheun Jee; Younbyoung Chae; Sung-Hoon Kim; Sung Joong Lee; Ik-Hyun Cho
Journal:  Mol Neurobiol       Date:  2015-01-13       Impact factor: 5.590

4.  Proteomic profiling in MPTP monkey model for early Parkinson disease biomarker discovery.

Authors:  Xiangmin Lin; Min Shi; Jeyaraj Gunasingh Masilamoni; Romel Dator; James Movius; Patrick Aro; Yoland Smith; Jing Zhang
Journal:  Biochim Biophys Acta       Date:  2015-01-22

5.  Combined treatment with acupuncture reduces effective dose and alleviates adverse effect of L-dopa by normalizing Parkinson's disease-induced neurochemical imbalance.

Authors:  Seung-Nam Kim; Ah-Reum Doo; Ji-Yeun Park; Hyunwoo J Choo; Insop Shim; Jongbae J Park; Younbyoung Chae; Bena Lee; Hyejung Lee; Hi-Joon Park
Journal:  Brain Res       Date:  2013-12-07       Impact factor: 3.252

6.  The antioxidative effect of electro-acupuncture in a mouse model of Parkinson's disease.

Authors:  Haomin Wang; Yanli Pan; Bing Xue; Xinhong Wang; Feng Zhao; Jun Jia; Xibin Liang; Xiaomin Wang
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

7.  Acupuncture enhances the synaptic dopamine availability to improve motor function in a mouse model of Parkinson's disease.

Authors:  Seung-Nam Kim; Ah-Reum Doo; Ji-Yeun Park; Hyungjin Bae; Younbyoung Chae; Insop Shim; Hyangsook Lee; Woongjoon Moon; Hyejung Lee; Hi-Joon Park
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

8.  The cortical and striatal gene expression profile of 100 hz electroacupuncture treatment in 6-hydroxydopamine-induced Parkinson's disease model.

Authors:  Li-Rong Huo; Xi-Bin Liang; Bo Li; Jian-Tao Liang; Yi He; Yan-Jun Jia; Jun Jia; Xiao-Li Gong; Fen Yu; Xiao-Min Wang
Journal:  Evid Based Complement Alternat Med       Date:  2012-01-26       Impact factor: 2.629

9.  Korean Red Ginseng protects dopaminergic neurons by suppressing the cleavage of p35 to p25 in a Parkinson's disease mouse model.

Authors:  Ye Lee Jun; Chang-Hwan Bae; Dongsoo Kim; Sungtae Koo; Seungtae Kim
Journal:  J Ginseng Res       Date:  2014-11-01       Impact factor: 6.060

10.  Systems biology of meridians, acupoints, and chinese herbs in disease.

Authors:  Li-Ling Lin; Ya-Hui Wang; Chi-Yu Lai; Chan-Lao Chau; Guan-Chin Su; Chun-Yi Yang; Shu-Ying Lou; Szu-Kai Chen; Kuan-Hao Hsu; Yen-Ling Lai; Wei-Ming Wu; Jian-Long Huang; Chih-Hsin Liao; Hsueh-Fen Juan
Journal:  Evid Based Complement Alternat Med       Date:  2012-10-18       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.